Cargando…
Tumoricidal, Temozolomide- and Radiation-Sensitizing Effects of K(Ca)3.1 K(+) Channel Targeting In Vitro Are Dependent on Glioma Cell Line and Stem Cell Fraction
SIMPLE SUMMARY: A potential new treatment for glioma patients is the blockade of K(Ca)3.1 potassium channels. In our study, we performed experiments with the K(Ca)3.1 blocker TRAM-34 in five glioma cell lines. To broaden our findings, effects on cultures enriched in glioma stem cells which are thoug...
Autores principales: | Stransky, Nicolai, Ganser, Katrin, Naumann, Ulrike, Huber, Stephan M., Ruth, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776522/ https://www.ncbi.nlm.nih.gov/pubmed/36551685 http://dx.doi.org/10.3390/cancers14246199 |
Ejemplares similares
-
Efficacy of combined tumor irradiation and K(Ca)3.1-targeting with TRAM-34 in a syngeneic glioma mouse model
por: Stransky, Nicolai, et al.
Publicado: (2023) -
K(Ca)3.1 Channels Confer Radioresistance to Breast Cancer Cells
por: Mohr, Corinna J., et al.
Publicado: (2019) -
Cancer-Associated Intermediate Conductance Ca(2+)-Activated K(+) Channel K(Ca)3.1
por: Mohr, Corinna J., et al.
Publicado: (2019) -
K(Ca)3.1 Channels and Glioblastoma: In Vitro Studies
por: Klumpp, Lukas, et al.
Publicado: (2018) -
Ion channels as molecular targets of glioblastoma electrotherapy
por: Abed, Tayeb, et al.
Publicado: (2023)